Skip to content

Effect of Local Ischemic Postconditioning with N-acetylcysteine during Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment-Elevation Acute Myocardial Infarction

Effect of Local Ischemic Postconditioning with N-acetylcysteine during Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment-Elevation Acute Myocardial Infarction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022977
Enrollment
Unknown
Registered
2019-05-06
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

Experimental Group:Combined therapy of N-acetylcysteine and local ischemic postconditioning
Control group:5% dextrose

Sponsors

Department of Cardiology, Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Chest pain = 12 hours; 2. Aged = 18 years; 3. STEMI (ST segment elevation in two or more adjacent leads of ECG: V2-V3 lead = 0.2mV in male or female = 0.15mV and/or other leads = 0.1mV); 4. Consent to emergency PCI treatment.

Exclusion criteria

Exclusion criteria: 1. Previous coronary artery bypass grafting; 2. Previous myocardial infarction; 3. Received thrombolytic therapy before coronary angiography; 4. Left main coronary artery disease requires coronary artery bypass grafting (CABG) or severe heart failure requires mechanical ventilation or intra-aortic ballon pump (IABP) implantation; 5. Life expectancy due to non-cardiac diseases is less than 1 year; 6. Patients who are participating in other clinical trials; 7. Researchers consider that patients are not eligible for the clinical trials for other factors.

Design outcomes

Primary

MeasureTime frame
myocardial infarct size;

Secondary

MeasureTime frame
net adverse clinical events;TIMI flow after PCI;

Countries

China

Contacts

Public ContactChen Lianglong

Fujian Medical University Union Hospital

lianglongchenxh@126.com+86 591-83342282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026